Lrp5 and bone formation: A serotonin-dependent pathway

Annals of the New York Academy of Sciences

Volumn 1192, Issue , 2010, Pages 103-109

  Yadav, Vijay K ^a   Ducy, Patricia ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

Bone formation; Htr1b receptor; Lrp5; Osteoblast proliferation; Serotonin

Indexed keywords

CYCLIC AMP; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; OXYGENASE; SEROTONIN; TRANSCRIPTION FACTOR; WNT PROTEIN;

ANIMAL EXPERIMENT; BIOSYNTHESIS; BONE MASS; CELL PROLIFERATION; CONFERENCE PAPER; DUODENUM; ENDOCRINE FUNCTION; GENE DELETION; MICROARRAY ANALYSIS; MOUSE; MOUSE STRAIN; NONHUMAN; OSSIFICATION; OSTEOBLAST; PHENOTYPE; PROTEIN BINDING; PROTEIN EXPRESSION; SEROTONIN BLOOD LEVEL;

MUS;

EID: 77950641024     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05312.x     Document Type: Conference Paper

References (25)

1. Gong, Y. et al. 2001. LDL Receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107: 513-523. (Pubitemid 33152786)
2. Boyden, L.M. et al. 2002. High bone density due to a mutation in LDL-receptor-related protein 5. N. Engl. J. Med. 346: 1513-1521.
3. Johnson, M.L. et al. 1997. Linkage of a gene causing high bone mass to human chromosome 11(11q12-13). Am. J. Hum. Genet. 60: 1326-1332.
4. Kato, M. et al. 2002. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, aWnt coreceptor. J. Cell Biol. 157: 303-314. (Pubitemid 34839826)
5. Wehrli,M. et al. 2000. Arrow encodes an LDL-receptorrelated protein essential for Wingless signalling. Nature 407: 527-530.
6. Tamai, K. et al. 2000. LDL-receptor-related proteins in Wnt signal transduction. Nature 407: 530-535.
7. Logan, C.Y.&R.Nusse. 2004. TheWnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20: 781-810. (Pubitemid 39488658)
8. Mao, J. et al. 2001. Low-density lipoprotein receptorrelated protein-5 binds to axin and regulates the canonical Wnt signaling pathway. Mol. Cell 7: 801-809. (Pubitemid 32436440)
9. Kikuchi, A., H. Yamamoto & S. Kishida. 2007.Multiplicity of the interactions of Wnt proteins and their receptors. Cell Signal 19: 659-671. (Pubitemid 46275377)
10. Holmen, S.L. et al. 2004. Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6. J. Bone Miner. Res. 19: 2033-2040.
11. Glass, D.A., 2nd et al. 2005. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev. Cell 8: 751-764. (Pubitemid 40585297)
12. Yadav, V.K. et al. 2008. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 135: 825-837.
13. Gershon, M.D. et al. 1990. 5-HT receptor subtypes outside the central nervous system. Roles in the physiology of the gut. Neuropsychopharmacology 3: 385-395.
14. Gershon, M.D. & J. Tack. 2007. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 132: 397-414. (Pubitemid 46127672)
15. Walther, D.J. et al. 2003. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299: 76.
16. Mann, J.J. et al. 1992. Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients. Arch. Gen. Psychiatry 49: 442-446.
17. Hanley, H.G., S.M. Stahl & D.X. Freedman. 1977. Hyperserotonemia and amine metabolites in autistic and retarded children. Arch. Gen. Psychiatry 34: 521-531. (Pubitemid 8108951)
18. Hediger, M.L. et al. 2007. Reduced bone cortical thickness in boys with autism or autism spectrum disorder. J. Autism Dev. Disord.
19. Haney, E.M. et al. 2007. Association of low bone mineral densitywith selective serotonin reuptake inhibitor use by older men. Arch. Intern. Med. 167: 1246-1251.
20. Diem, S.J. et al. 2007. Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch. Intern. Med. 167: 1240-1245.
21. Schneeweiss, S. & P.S. Wang. 2004. Association between SSRI use and hip fractures and the effect of residual confounding bias in claims database studies. J .Clin. Psychopharmacol. 24: 632-638. (Pubitemid 39518660)
22. Richards, J.B. et al. 2007. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch. Intern. Med. 167: 188-194.
23. Warden, S.J. et al. 2005. Inhibition of the serotonin (5- hydroxytryptamine) transporter reduces bone accrual during growth. Endocrinology 146: 685-693.
24. Westbroek, I. et al. 2001. Expression of serotonin receptors in bone. J. Biol. Chem. 276: 28961-28968.
25. Fu, L. et al. 2005. The molecular clock mediates leptinregulated bone formation. Cell 122: 803-815.